Literature DB >> 3311903

Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon.

K Kett1, P Brandtzaeg.   

Abstract

The subclass distribution of IgA producing cells was determined by paired immunofluorescence staining in colonic specimens from 10 patients with ulcerative colitis and eight with Crohn's disease. Compared with normal colonic mucosa, the percentage of IgA1 immunocytes showed a striking increase in both disorders. The proportion of mucosal IgA1 cells was significantly higher (p less than 0.05) in ulcerative colitis (median, 71.2%) than in Crohn colitis (median, 56.9%). Within each category of specimens no significant differences were noted between luminal and basal mucosal zones. The submucosal proportion of IgA1 cells was, however, significantly higher than the mucosal one in both ulcerative colitis (median, 89.1%; p less than 0.002) and Crohn colitis (median, 91.8%; p less than 0.005). The mucosal shift towards IgA1 production paralleled the magnitude of the submucosal IgA1 cell proportion in individual tissue samples. Taken together with the previously reported dramatic increase of local IgG production (particularly observed in the submucosa and basal parts of the mucosa), our findings indicated that there is an influx and/or proliferation of B cells representing systemic secondary immunity in the lesions of both diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311903      PMCID: PMC1433133          DOI: 10.1136/gut.28.8.1013

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  43 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  THE NORMAL HUMAN INTESTINAL MUCOSA AS A MAJOR SOURCE OF PLASMA CELLS CONTAINING GAMMA-A-IMMUNOGLOBULIN.

Authors:  P A CRABBE; A O CARBONARA; J F HEREMANS
Journal:  Lab Invest       Date:  1965-03       Impact factor: 5.662

3.  Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique.

Authors:  P Brandtzaeg
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

4.  Intestinal immunoglobulins in ulcerative colitis.

Authors:  J Söltoft; V Binder; E Gudmand-Höyer
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Human immunoglobulin A: production of an Fc fragment by an enteric microbial proteolytic enzyme.

Authors:  S K Mehta; A G Plaut; N J Calvanico; T B Tomasi
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

6.  Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis.

Authors:  P Brandtzaeg; K Baklien; O Fausa; P S Hoel
Journal:  Gastroenterology       Date:  1974-06       Impact factor: 22.682

7.  Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa.

Authors:  P Brandtzaeg; K Baklien
Journal:  Scand J Gastroenterol Suppl       Date:  1976

8.  In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. II. Pathological tissues.

Authors:  D B McClelland; D J Shearman; R F Lai A Fat; R van Furth
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

9.  Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains.

Authors:  J P Vaerman; J F Heremans
Journal:  Science       Date:  1966-08-05       Impact factor: 47.728

10.  The plasma cells in inflammatory disease of the colon: a quantitative study.

Authors:  J M Skinner; R Whitehead
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

View more
  10 in total

Review 1.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.

Authors:  Michael E Burczynski; Ron L Peterson; Natalie C Twine; Krystyna A Zuberek; Brendan J Brodeur; Lori Casciotti; Vasu Maganti; Padma S Reddy; Andrew Strahs; Fred Immermann; Walter Spinelli; Ulrich Schwertschlag; Anna M Slager; Monette M Cotreau; Andrew J Dorner
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

3.  Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC class II (HLA-D) antigens.

Authors:  L K Trejdosiewicz; S Badr-el-Din; C J Smart; G Malizia; D J Oakes; R V Heatley; M S Losowsky
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

4.  Salivary SIgA and SIgA 1 in coeliac disease, inflammatory bowel disease and controls.

Authors:  R H Warner; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1999 Jan-Mar       Impact factor: 1.568

5.  Raised number of jejunal IgG2-producing cells in untreated adult coeliac disease compared with food allergy.

Authors:  T O Rognum; K Kett; O Fausa; U Bengtsson; A Kilander; H Scott; P I Gaarder; P Brandtzaeg
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

6.  Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity.

Authors:  Mathieu Uzzan; Jerome C Martin; Luka Mesin; Alexandra E Livanos; Tomas Castro-Dopico; Ruiqi Huang; Francesca Petralia; Giuliana Magri; Shashi Kumar; Qing Zhao; Adam K Rosenstein; Minami Tokuyama; Keshav Sharma; Ryan Ungaro; Roman Kosoy; Divya Jha; Jeremy Fischer; Harpriya Singh; Mary E Keir; Nandhini Ramamoorthi; William E O' Gorman; Benjamin L Cohen; Adeeb Rahman; Francesca Cossarini; Akihiro Seki; Louise Leyre; Sonia Tejedor Vaquero; Sakteesh Gurunathan; Emilie K Grasset; Bojan Losic; Marla Dubinsky; Alexander J Greenstein; Zoe Gottlieb; Peter Legnani; James George; Haritz Irizar; Aleksandar Stojmirovic; Carrie Brodmerkel; Andrew Kasarkis; Bruce E Sands; Glaucia Furtado; Sergio A Lira; Zewen K Tuong; Huaibin M Ko; Andrea Cerutti; Charles O Elson; Menna R Clatworthy; Miriam Merad; Mayte Suárez-Fariñas; Carmen Argmann; Jason A Hackney; Gabriel D Victora; Gwendalyn J Randolph; Ephraim Kenigsberg; Jean Frederic Colombel; Saurabh Mehandru
Journal:  Nat Med       Date:  2022-02-21       Impact factor: 87.241

7.  Local immunity in ulcerative colitis: evidence for defective secretory IgA production.

Authors:  S Badr-el-Din; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

8.  The human intestinal IgA response; burning questions.

Authors:  Jo Spencer; Linda S Klavinskis; Louise D Fraser
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

9.  The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease.

Authors:  Tomohiro Terasaka; Haruhito A Uchida; Ryoko Umebayashi; Keiko Tsukamoto; Keiko Tanaka; Masashi Kitagawa; Hitoshi Sugiyama; Hiroaki Tanioka; Jun Wada
Journal:  BMC Nephrol       Date:  2016-09-05       Impact factor: 2.388

10.  Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.

Authors:  Johanna Rehnberg; Adina Symreng; Jonas F Ludvigsson; Louise Emilsson
Journal:  J Am Soc Nephrol       Date:  2020-11-11       Impact factor: 10.121

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.